Search
for

    Glossary Troglitazone

    medication for type 2 diabetes, withdrawn due to liver toxicity

    Troglitazone, also known as Rezulin, is a medication that was used to treat type 2 diabetes by improving insulin sensitivity. However, it was withdrawn from the market due to severe liver toxicity and associated health risks.

    Research

    5 / 187 results

      research Treatment of Lipodystrophy with Troglitazone

      1 citations , June 2001 in “Annals of Internal Medicine”
      This letter to the editor discusses data from a study on troglitazone for lipodystrophy, noting significant increases in subcutaneous fat without dietary changes.

      research Obesity and polycystic ovary syndrome

      90 citations , January 2021 in “Clinical Endocrinology”
      This review discusses the impact of weight gain and obesity on the development of polycystic ovary syndrome and explores lifestyle strategies to manage the condition, without reporting new clinical results.

      research INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME

      39 citations , September 2000 in “Obstetrics and Gynecology Clinics of North America”
      This article reviews evidence on hyperinsulinemia and insulin resistance in women with polycystic ovary syndrome and evaluates therapeutic responses to insulin-lowering agents, reporting no new clinical findings.

      research Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome

      32 citations , July 2001 in “Endocrine Practice”
      This review discusses the therapeutic use of insulin-sensitizing agents in polycystic ovary syndrome, reporting improved ovulation, insulin sensitivity, and reduction of hyperandrogenism, but calls for larger studies to confirm these effects.

      research Insulin Resistance and Polycystic Ovary Syndrome

      November 2004 in “John Wiley & Sons, Ltd eBooks”
      This chapter reviews polycystic ovary syndrome (PCOS), focusing on its definition, causes, and treatment approaches, but reports no new research findings.

    Learn

    — no results

    Community Join

    — no results